In many ways, 2017 Annual Report is a testament to our highly successful approach of performing clinical pharmacology projects that are centred around collecting valuable information regarding the investigational compounds. In this report, we highlight some of the activities that CHDR embarked upon in 2017, and you will find information regarding our three key themes: developing drugs, developing methods, and developing people. Together with our continued commitment to research, investment in operations, and our active role in helping develop new guidelines, this approach has contributed to yet another successful year in CHDR’s history.
